• Journal of Science and Technology Studies
• /
• v.12 no.1
• /
• pp.1-43
• /
• 2012

This paper examines the American Civil Liberties Union(ACLU)'s recent legal challenge on patents held by Myriad Genetics on two genes (BRCA1 and BRCA2) associated with a high risk of breast and ovarian cancer. Instead of analyzing the ACLU's objections to the BRCA patents in terms of its legal technicalities and normative ethical principles, this paper seeks to situate this legal case in the broader historical context of the shifting understanding of the relationship between private ownership, economic development, and the public interest in academic sciences. This paper first briefly chronicles a series of scientific developments and key legal decisions involving patenting of life forms, including genetically engineered micro-organisms animals and biological materials of human origins like cell cultures and genes, that led to the US Patent and Trademark Office(USPTO)'s official guidelines on human gene patenting in 2001. At another level, this paper analyzes the expansion of the scope of intellectual property rights in the life sciences in terms of shifting economic and legal assumptions about public knowledge and its role for economic development in the 1970s. I then show how these economic, legal, and ethical ideas that linked private ownership and the public interest have been challenged from the 1990s, calling for revisions in intellectual property laws regarding a wide array of life forms. The tragedy of the anticommons in human gene patenting, according to ACLU, has severely undermined creative scientific activities, medical innovations, access to health care and rights to life among cancer patient groups. ACLU's objection to human gene patenting on several US-constitutional grounds in turn suggests issues regarding intellectual property are critically linked to vital issues pertinent to the creative communities in arts and sciences, such as free exchange of ideas, censorship and monopoly, and free expression and piracy etc.

• 발명특허
• /
• v.25 no.2 s.287
• /
• pp.14-15
• /
• 2000

• Proceedings of the Korea Information Processing Society Conference
• /
• 2008.11a
• /
• pp.603-606
• /
• 2008

최근 들어 분자생물학의 급속한 발전과 2001년 인간유전체사업의 완료로 인해 전세계적으로 엄청난 양의 유전정보가 공개되었다. 유전자 서열정보는 그 양이 방대하고 다양하기에 데이터베이스 구축 및 분석을 위하여 고성능 컴퓨터 및 정보기술 기법이 필요하다. 그래서 컴퓨터를 활용하여 생물학적 데이터를 수집, 관리, 저장, 평가, 분석하는 연구분야인 생명정보학(바이오인포매틱스)이라는 학문이 지속적으로 발전하고 있다. 이런 생명정보학 발전에 발맞추어 한국과학기술정보연구원(KISTI)에서는 정보기술을 기반으로 한 생명정보 인프라를 구축하여 생명과학 연구자들에게 제공하고 있다. 본 논문에서는 생명정보 데이터베이스중에서 연구자들이 가장 많이 이용하는 유전자 데이터베이스인 Genbank를 활용 및 분석하여 KISTI에서 운영하는 학술논문 제공 사이트인 NDSL(http://scholar.ndsl.kr)과 연계 가능한 서비스 모델을 개발하기 위하여 1) NCBI FTP 사이트에서 Genbank 데이터를 수집하고, 2) Genbank 텍스트 파일을 유전자 기본정보와 참고 데이터베이스로 재구축하며, 3) Genbank refrence 필드에서 논문 및 특허 정보 추출을 통한 새로운 테이블을 생성하여 NDSL과 연계 가능한 서비스 모델을 제안하였다.

• The Korean Society of Law and Medicine
• /
• v.17 no.1
• /
• pp.45-105
• /
• 2016

The purposes of this study is to debate the duty to share and right to be forgotten of human materials and human genome information in modern personalized medicine. This study debates the use of human materials and human genome information in modern personalized medicine from the perspectives of the duty to share and right to be forgotten. The arguments are based on personal and community aspects. In general, human genome information is considered the personal property of an individual. Nevertheless, on thinking carefully, we can understand that human materials and human genome information have both personal and community aspects. In this study, cases are examined including a HeLa cell, Guaymi woman cell strain, and Hagahai man cell, to support various debates an genetic information for database construction in personalized medicine. Finally, using moral theories, this study attempts to synthesize the dialectics of the duty to share and right to forget regarding the use of human materials and human genome information in medicine.